Acroscell, the major division of Creative Bioarray, is a global leading provider of quality services with professional electrophysiological techniques, aiming to promote the research development of drug screening and profiling, especially for the academia, pharmaceutical, and biotechnology industries. Recently, Acroscell launches a full complement of visual electrophysiology testing services to support the research of visual disorders. —
Visual electrophysiology is a collection of advanced technologies used to test cell function along the entire visual pathway (from the retina to the optic nerve to the main visual cortex of the brain). Visual electrophysiology measures and records the electrical signals that occur in these areas in response to visual stimuli. These tests are used to help study various visual disorders. Acroscell provides visual electrophysiological tests that can help diagnose unexplained vision loss; unusual complaints about visual symptoms; visual field loss inconsistent with clinical manifestations; potential for glaucoma or genetic diseases; marginal or boundary results from other tests.
Acroscell's visual electrophysiology and psychophysical services provide a complete test supplement, including electroretinogram (ERG), which is a chronic potential change on the retina. ERG is produced after the retina is stimulated by reflected light. It represents the overall electrical activity of all layers of the retina from photoreceptor cells to amacrine cells. In addition, the origin of EOG is the area between the choroid and the retina. Retinal pigment epithelium is the most important structure for potential generation, and neuroepithelium also plays a role. And visual evoked potential (VEP), which belongs to cortical evoked potential. It is a cluster of electrical signals generated by the cerebral cortex in response to visual stimuli. Acroscell also provides spatial resolution and color vision and color sensitivity tests. These tests can accurately record the bioelectric changes of neurons in the visual system from the peripheral retina to the central visual cortex.
Visual electrophysiology technology can be used to help distinguish visual pathway diseases in children and patients with special needs, who either cannot be checked by traditional tests or cannot undergo surgery such as visual field tests. In addition, ERG and VEP tests can supplement existing test methods for earlier and more accurate diagnosis. It can also guide clinical treatment and make prognostic judgments.
“With our advanced electrophysiological screening platform, Acroscell can provide a variety of standard and customized drug safety and pharmacological testing methods and panels for drug screening and analysis. Our team has extensive drug discovery capabilities, expertise, and proven experience to successfully achieve various project goals in terms of delivering high-quality data and on-time performance.” said Hannah Cole, the marketing director of Creative Bioarray, she also claimed, “Acroscell provides project consulting for various pre-clinical studies to help you with project management and execution. Our in-house professionals are equipped with confidence and experience to achieve your highest quality drug development goals.”
As a mature division of Creative Bioarray, Acroscell definitely will be the ideal and reliable innovation partner in research endeavors. With the support of professional scientists and years of experience, We are capable to provide a knowledgeable, collaborative and flexible service to our clients so as to accelerated drug development and improved research quality for worldwide projects.
Name: Hannah Cole
Email: Send Email
Organization: Acroscell | Creative Bioarray
Address: New York 11967, USA
Phone: 1 631 386 8241
Release ID: 88994513